Table 5.
Univariate analysis (Survival) | Multivariate analysis (Cox Proportional Hazards Model)** | |||||||
---|---|---|---|---|---|---|---|---|
Variable | Category | N | Median Survival in months (Range) | Hazard Ratio (CI) | p value | Adjusted p* value | CI | P value |
Gender | Female | 18 | 37.9 (3.5 - 59.2) | 0.66 (0.31- 1.42) | 0.281 | |||
Male | 22 | 26.4 (1.1 - 72.9) | 1 | |||||
Age | <65 | 27 | 39.1 (1.1 – 72.9) | 0.48 (0.20 – 1.15) | 0.058 | 0.41 (0.16 – 1.05) | 0.066 | |
≥65 | 13 | 22.4 (1.7 - 59.2) | 1 | |||||
ECOG Performance score | 0 | 30 | 56.2 (3.5 - 72.9) | 0.13 (0.03 – 0.55) | <0.0001 | 0.008 | 0.04 (0.009 – 0.19) | 0.0001 |
>0 | 10 | 6.9 (1.1 - 10.6) | 1 | |||||
Liver replacement by tumor % | ≤ 25% | 32 | 56.1 (1.1 - 72.9) | 0.29 (0.09 – 0.98) | 0.0019 | 0.015 | 0.63 (0.20 – 1.91) | 0.41 |
> 25% | 8 | 15.4 (1.7 – 34.4) | 1 | |||||
Lesions >4 | No | 3 | 37.9 (4 - 37.9) | 0.79 (0.16 – 3.91) | 0.755 | |||
Yes | 37 | 29.9 (1.1 - 72.9) | 1 | |||||
Extrahepatic disease | No | 26 | 39.1 (1.1 - 72.9) | 0.53 (0.22 - 1.29) | 0.108 | 0.73 (0.25 – (2.06) | 0.55 | |
Yes | 14 | 22.1 (3.5 - 56.2) | 1 | |||||
Albumin | ≥3.5 g/dL | 15 | 58.9 (1.7 – 72.9) | 0.39 (0.18 – 0.84) | 0.017 | 0.08 | 0.45 (0.15 – 1.34) | 0.15 |
<3.5 g/dL | 25 | 22.0 (1.1 – 56.1) | 1 | |||||
Bilirubin | ≤1.2 mg/dL | 38 | 37.9 (1.1 – 72.9) | 0.14 (0.004 – 5.02) | 0.002 | 0.016 | 0.08 (0.01-0.74) | 0.02 |
>1.2 mg/dL | 2 | 5.2 (1.7 – 8.7) | 1 |
Adjusted for multiple comparison (correction factor=8)
Factors were included in multivariate analysis if p <.25 in univariate analysis (unadjusted for multiple comparisons)
Abbreviations: ECOG: Eastern Cooperative Oncology Group